Our Blog

J & J to pay billions for fraud regarding Risperdal

In a nearly record-setting pay out, pharmaceutical industry giant Johnson & Johnson (J&J) and some of its subsidiaries will pay more than $2.2 billion in civil and criminal fines stemming from the manufacturer’s conduct surrounding its drug Risperdal, and two other drugs, Invega and Natrecor. “The conduct at issue in this case jeopardized the health and safety of patients and damaged the public trust,” said Attorney General Eric Holder.  “This multibillion-dollar resolution demonstrates the Justice Department’s firm commitment to preventing and combating all forms of health care fraud.  And it proves our determination to hold accountable any corporation that breaks… [Read More]

Read More

Study Confirms Transvaginal Mesh Adds No Benefits

Juries have been finding against the manufacturers of transvaginal mesh (TVM) and awarding significant verdicts to women harmed by these products. And now a new study has found there is no added benefit to implanting TVM into women who have surgery to correct pelvic organ prolapse, or “POP.” A Georgetown University study of thousands of Medicare beneficiaries who had transvaginal mesh implanted to correct POP found there was no variation in cure rates when compared to traditional treatments.  The research team was led by Dr. Robert Gutman, and studied more than 7,000 patients. TVM products have been used to correct… [Read More]

Read More

Phillips Grossman Sues Antidepressant Drug Makers

As evidence continues to mount that some antidepressants can cause birth defects, Phillips Grossman is filing lawsuits on behalf of families whose children were born with defects caused by the drugs. At issue are the categories of anti-depressant medications referred to as “SSRI” (selective serotonin reuptake inhibitors) and “SNRI” (serotonin norepinephrine reuptake inhibitors). The most well known of the SSRI drugs is Prozac, which was the first to be approved by the Food and Drug Administration (FDA) in the 1990s.  Other popular SSRI drugs include Celexa, Lexapro, Zoloft and Paxil, among others. SNRI drugs include Effexor and Cymbalta. SSRI drugs… [Read More]

Read More

Sanders Viener Grossman files Januvia, Byetta lawsuits

On September 3, 2013, Sanders Viener Grossman, LLP (affiliate of Phillips Grossman, PLLC) filed wrongful death lawsuits against Merck & Co. Inc., Amylin Pharmaceuticals, Inc. and Eli Lily & Co. in the Southern District of California in San Diego.  Today those cases were transferred to the Multidistrict Litigation (MDL) In Re: Incretin-Based Therapies Products Liability Action, Case MDL No. 2452.  More than 50 other cases have also been filed in the MDL, and many more lawsuits are expected. Plaintiffs claim the drugs Byetta and Januvia caused the decedents to develop pancreatic cancer, which caused their deaths.  Byetta and Januvia are… [Read More]

Read More

FDA Act Allow Generic Drug Maufacturers Adjust Safety Labels

In a significant move to protect those harmed by generic drugs, the Food and Drug Administration (FDA) recently indicated its intent to create a new rule in which generic drug manufacturers would be required to modify and strengthen safety labels to warn of side effects that become known after the prescription medication is on the market. Currently, there is no FDA rule requiring generic manufacturers to do this. Since 2011, generic drug manufacturers have enjoyed protection from lawsuits alleging failure to warn of known risks and complications of its drugs as long as the safety label matched its brand-name counterpart. … [Read More]

Read More

Firm Attorney Vicki Maniatis Conquers Ironman

When it comes to winning legal arguments, attorney Vicki Maniatis knows a thing or two about preparation and tenacity.  But her preparation and tenacity doesn’t stop at the courtroom steps.  When not charging forward against big pharmaceutical companies on behalf of those injured by bad drugs, Maniatis has been outside training for a 2.4 mile swim in cold waters, a 112-mile bike ride through forests and mountains, and capping it off with a 26.2-mile run past a waterfall and into a quaint village to the finish for that beast of a race called an Ironman. And finish she did.  On… [Read More]

Read More

Plaintiff wins $2 million against TVM Manufacturer Bard

A Charleston, West Virginia jury recently awarded a Georgia woman a total of $2 million against C. R. Bard Industries, one of the manufacturers of transvaginal mesh (TVM) products, in one of the first cases to go to trial. Finding the company guilty of “fraud, malice or wantonness,” the jury awarded plaintiff Donna Sisson $250,000 for her pain and suffering from the defective Avaulta mesh device implanted in her in 2009 to correct pelvic organ prolapse (POP).  It further punished Bard by awarding $1.75 million in punitive damages against Bard. Sisson, a public health nurse from Georgia, had pain, bleeding… [Read More]

Read More

Promoting improper off-label use of its bone-growth spinal product Infuse

Sanders Viener Grossman, The Phillips Firm and Hodes Milman file lawsuit against device manufacturer Medtronic, Inc. and Medtronic Sofamor Danek for promoting improper off-label use of its bone-growth spinal product Infuse® Accusing Medtronic, Inc., of encouraging doctors to use its bone-growth products in ways not approved by the Federal Drug Administration (FDA), commonly referred to as “off label” use, Sanders Viener Grossman, LLP recently filed its first lawsuit (along with The Philips Firm and Hodes Milman Liebeck Mosier ) against Medtronic and Medtronic Sofamor Danek in Los Angeles Superior Court, California. This is not the first lawsuit filed and many… [Read More]

Read More

Wonder why your doctor didn’t prescribe the cheaper generic drug?

Study finds drug company pay may be the reason Human nature being what it is, this may come as no surprise.  But a new study has found that pharmaceutical companies’ compensation to doctors in the form of cash, meals and travel, result in doctors prescribing that company’s brand name drug more often than not.  And the higher the payments to the doctors, the more prescriptions the doctor writes for that drug. According to “First, Do No Harm: Financial Conflicts in Medicine,” an August 2, 2013 study posted on the Social Science Research Network, doctors were much more likely to prescribe… [Read More]

Read More

Physician Payment Sunshine Act | Section 6002

What can make the sun shine? New Federal Rule, “Physician Payment Sunshine Act—Section 6002” requiring payments to doctors by medical device, pharmaceutical and biologics companies to be made public. The Federal Government, with the help of the Centers for Medicare & Medicaid Services (“CMS”), has enacted a law intended to help protect and inform patients. The Physician Payment Sunshine Act is a part of the new federal Affordable Care Act. Pharmaceutical, medical device and biologics companies must now reveal certain compensation they pay to doctors Beginning August 1, 2013, the Sunshine Act will require manufacturers who participate in federal health programs to… [Read More]

Read More

Phillips Law Firm files the first Granuflo/NaturaLyte cases in California

The Phillips Law Firm has taken the lead in California state court, filing the first cases against Fresenius Medical Care, the manufacturer of Granuflo and Naturalyte dialysis products.  The FDA recalled Granuflo and Naturalyte in 2012 because it found the products significantly increase the risk of sudden cardiac death in dialysis patients. The Phillips Law Firm has filed numerous cases against Fresenius on behalf of victims seriously injured or killed by Fresenius’s Granuflo product.  In March 2013, the firm filed a special motion asking the California Judicial Council to coordinate the California state court lawsuits and place them before the… [Read More]

Read More

Marc Grossman Elected to Board of Directors for New York Trial Lawyers Assn

Marc Grossman, a partner with Phillips Grossman, has been elected to the New York State Trial Lawyers Association Board of Directors. The NYSTLA has more than 4,600 members across New York, and was formed in 1953 to protect the interests of injured people, and to recognize “ethical, well-trained lawyers.” Mr. Grossman, a trial lawyer since 1993, has represented thousands of personal injury victims for a multitude of injuries, including large groups of people injured by defective drugs and medical devices.  He has obtained numerous multimillion-dollar verdicts and settlements for his clients, and was involved in securing a $4.85 billion settlement… [Read More]

Read More

Free Case Evaluation

Fill out this form for a FREE, Immediate, Case Evaluation
1615
<